Literature DB >> 22212413

Retrospective analysis on the impact of tuberculosis on patients with systemic lupus erythematosus (SLE).

Chang-Ran Zhang1, Yuan-Yuan Niu, Jian-Cong Lin, Wen-Hui Wu, Ming Li, Jian-Feng Li.   

Abstract

Up to now, there have been few reports concerning changes in lupus activity and immune indices of tuberculosis in patients with systemic lupus erythematosis (SLE). A retrospective investigation was given to survey the case data of SLE patients companied with tuberculosis that were treated in our hospital from 2001 to 2010 and compared with that of sex- and age-matched patients with single SLE. Changes in autoantibodies, lupus activity, inflammatory indices, positive rates of tuberculin (PPD) test and tuberculosis antibody (TB-Ab) of both groups were observed. It was indicated by results that ANA antibody level and positive rates of anti-Sm, anti-SSA and anti-SSB antibodies were significantly lower in the TB group than those in the control group (P < 0.05); C3 and C4 levels were significantly higher in the TB group than those in the control group; damage of hematological system (predominantly platelet) was less severe in the TB group than that in the control group (P < 0.05); no significant differences in IgG, IgM and IgA were noted between two groups (P > 0.05); ESR, C-reactive protein and LDH levels were significantly higher in the TB group than those in the control group (P < 0.05); PPD-IgG were significantly higher in the TB group than those in the control group (P < 0.05). These results suggested that after SLE patients were infected with tuberculosis, immune function was altered and lupus activity was inhibited as well.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22212413     DOI: 10.1007/s00296-011-2358-0

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  12 in total

1.  Incidence of tuberculosis among patients receiving treatment with oral corticosteroids.

Authors:  P N Agrawal; D Gupta; A N Aggarwal; D Behera
Journal:  J Assoc Physicians India       Date:  2000-09

Review 2.  The use of laboratory tests in the diagnosis of SLE.

Authors:  W Egner
Journal:  J Clin Pathol       Date:  2000-06       Impact factor: 3.411

3.  [Detection and clinical significance of PPD-IgG antibody in cerebrospinal fluid by ABC-ELISA method].

Authors:  L B Song; M H Han
Journal:  Zhonghua Jie He He Hu Xi Za Zhi       Date:  1994-04

4.  [The clinical significance of detection of anti-PPD-IgG secreting cell, adenosine deaminase and anti-PPD-IgG antibody in pleural effusion].

Authors:  Y J Zhou; Y Y Gao
Journal:  Zhonghua Jie He He Hu Xi Za Zhi       Date:  1994-04

5.  Tuberculosis in systemic lupus erythematosus in an endemic area and the role of isoniazid prophylaxis during corticosteroid therapy.

Authors:  Mo Yin Mok; Yi Lo; Tak Mao Chan; Woon Sing Wong; Chak Sing Lau
Journal:  J Rheumatol       Date:  2005-04       Impact factor: 4.666

6.  Risk factors and clinical features for tuberculosis among patients with systemic lupus erythematosus in Hong Kong.

Authors:  Lai-Shan Tam; Edmund K Li; Shiu-Man Wong; Cheuk-Chun Szeto
Journal:  Scand J Rheumatol       Date:  2002       Impact factor: 3.641

Review 7.  Infections in systemic lupus erythematosus.

Authors:  S V Navarra; M S N Leynes
Journal:  Lupus       Date:  2010-10       Impact factor: 2.911

8.  Efficacy of isoniazid prophylaxis in patients with systemic lupus erythematosus receiving long term steroid treatment.

Authors:  S Gaitonde; E Pathan; A Sule; G Mittal; V R Joshi
Journal:  Ann Rheum Dis       Date:  2002-03       Impact factor: 19.103

9.  Quantification of regulatory T cells in patients with systemic lupus erythematosus.

Authors:  Jose C Crispin; Araceli Martínez; Jorge Alcocer-Varela
Journal:  J Autoimmun       Date:  2003-11       Impact factor: 7.094

10.  The 1982 revised criteria for the classification of systemic lupus erythematosus.

Authors:  E M Tan; A S Cohen; J F Fries; A T Masi; D J McShane; N F Rothfield; J G Schaller; N Talal; R J Winchester
Journal:  Arthritis Rheum       Date:  1982-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.